Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000638 |
Amiodarone |
Amiodarone results in decreased expression of FUT4 mRNA | decreases expression | 17991464
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of FUT4 mRNA | affects expression | 16483693
|
D003913 |
Dextroamphetamine |
Dextroamphetamine results in increased expression of FUT4 mRNA | increases expression | 16715494
|
D003513 |
Cycloheximide |
Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of FUT4 mRNA] | decreases reaction|increases expression | 11007951
|
D002117 |
Calcitriol |
Calcitriol results in decreased expression of FUT4 mRNA | decreases expression | 16002434
|
D004317 |
Doxorubicin |
Doxorubicin results in decreased expression of FUT4 protein | decreases expression | 17852453
|
D013749 |
Tetrachlorodibenzodioxin |
Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of FUT4 mRNA] | decreases reaction|increases expression | 11007951
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of FUT4 mRNA | increases expression | 11007951
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.24 | 11752688 15322242 14514962 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.95 | 18287403 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
2.62 | 17418594 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.77 | 16835633 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.87 | 21441931 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.21 | 11748828 |
MESH:D001145 |
Arrhythmias, Cardiac |
|
Amiodarone |
4.07 | 18218290 20041841 18057881 |
MESH:D001281 |
Atrial Fibrillation |
|
Amiodarone |
4.11 | 18651412 19698954 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Amiodarone |
10.00 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
10.00 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.23 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.93 | 15746008 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
5.14 | 14601052 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
4.07 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
Calcitriol |
1.93 | 11237771 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
1.93 | 15136595 16595493 18695136 16322301 19526202 15692762 15939500 16115903 16264153 11325840 18628466 16826403 16096432 17426702 15994142 15567936 16935488 18234424 15993339 17369602 17983394 18382427 15634643 15668708 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.93 | 20435547 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
5.25 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
3.02 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
2.25 | 17876044 16234567 16023760 18059187 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
3.27 | 1485588 16201981 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Calcitriol |
5.13 | 11237771 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
5.13 | 6189445 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.50 | 18850075 18670907 16120746 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.70 | 15792986 16109756 16455267 16364871 17382496 17131338 17007740 16731534 16612575 16651473 16278810 15476868 16952015 18627295 15811867 17308081 16242529 15505089 17924179 17519947 17928571 17329180 17351982 17974986 16269455 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Amiodarone |
6.24 | 15710769 19225199 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
6.24 | 16243910 17334414 |
MESH:D002341 |
Carotid Artery Thrombosis |
|
Amiodarone |
5.48 | 18974383 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.41 | 16835633 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.20 | 12621046 15340226 16354765 8697196 15668235 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
2.14 | 18802399 18259882 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.31 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 15322242 10048152 20055451 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.72 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Amiodarone |
6.69 | 15265979 18218290 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
6.69 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
6.69 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
8.79 | 18602426 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
8.79 | 11462148 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.65 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.35 | 16714409 15322242 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Calcitriol |
4.26 | 15138306 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
3.62 | 17359293 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.29 | 10568697 9294722 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
5.60 | 18037988 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.21 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Amiodarone |
3.80 | 14986274 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.81 | 11858732 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
4.98 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
3.31 | 20067830 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
3.52 | 17150277 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
5.04 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
3.70 | 15692506 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.46 | 10048152 11294989 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.67 | 12587719 16330681 16707910 16879835 16144979 16244372 17888722 17875725 18674790 14766674 16244371 16495754 18006777 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
3.50 | 17481944 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
4.18 | 15692506 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.62 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Amiodarone |
9.76 | 15265979 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
9.76 | 16120746 15340226 12621046 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
3.65 | 17606976 18501091 15147373 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.49 | 16959395 15340226 18606429 16354765 8697196 |
MESH:D006937 |
Hypercholesterolemia |
|
Amiodarone |
4.15 | 8137927 9751232 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.99 | 18850075 18670907 |
MESH:D007037 |
Hypothyroidism |
|
Amiodarone |
4.87 | 18020914 17991464 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
1.98 | 12200463 12878042 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.62 | 16580747 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
3.20 | 16775033 15369732 15699352 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
4.44 | 16707910 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
5.60 | 16085563 |
MESH:D008064 |
Lipidoses |
|
Amiodarone |
3.70 | 17567588 15342952 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
2.50 | 16595196 16439617 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.50 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
1.80 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
6.45 | 17085340 16842330 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
6.45 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
Amiodarone |
3.79 | 17391786 11989578 15350150 |
MESH:D008171 |
Lung Diseases |
|
Amiodarone |
3.55 | 12587719 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Amiodarone |
4.92 | 18516814 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
2.46 | 17418594 6189445 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.46 | 11884234 19555203 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
3.65 | 16098063 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
4.02 | 17654614 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.93 | 15621674 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
3.19 | 15458769 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
2.32 | 16827129 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
3.15 | 17638057 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.78 | 15792986 |
MESH:D009041 |
Motion Sickness |
|
Dextroamphetamine |
5.96 | 1613127 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
5.19 | 17415656 |
MESH:D009181 |
Mycoses |
|
Amiodarone |
5.34 | 12754197 17974566 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
3.04 | 15857846 19429709 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.24 | 12213967 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
3.04 | 18259882 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
5.13 | 16899518 16636307 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
4.25 | 16889571 15640375 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.54 | 14600291 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
3.39 | 15555623 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
4.34 | 15930896 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.69 | 12520081 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
5.60 | 17983394 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
5.60 | 17638057 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.89 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.59 | 11896295 11222880 11118676 11399792 |
MESH:D011470 |
Prostatic Hyperplasia |
|
Calcitriol |
5.18 | 15572423 |
MESH:D011471 |
Prostatic Neoplasms |
|
Calcitriol |
3.43 | 16644109 16289102 12479363 18247401 15754350 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
3.43 | 16888761 18437689 15749863 15897917 16729912 16868541 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Amiodarone |
2.94 | 12490602 11597910 12832656 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
4.58 | 17922066 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.17 | 18990726 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
4.25 | 17203757 15625365 18313854 16767912 15675481 17710206 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
4.57 | 14601052 16326096 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
5.19 | 17846226 |
OMIM:609620 |
SHORT QT SYNDROME 1 |
|
Amiodarone |
5.48 | 18724381 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
6.07 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
6.07 | 16192470 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.93 | 15625365 17203757 16767912 |
MESH:D013276 |
Stomach Ulcer |
|
Amiodarone |
3.59 | 18087811 |
MESH:D013610 |
Tachycardia |
|
Amiodarone |
4.62 | 11238279 |
MESH:D017180 |
Tachycardia, Ventricular |
|
Amiodarone |
4.52 | 19225199 |
MESH:D013959 |
Thyroid Diseases |
|
Amiodarone |
13.58 | 19731979 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
13.58 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
3.58 | 17909728 16010429 |
MESH:D013971 |
Thyrotoxicosis |
|
Amiodarone |
5.22 | 19584973 18020914 |
MESH:D016171 |
Torsades de Pointes |
|
Amiodarone |
4.59 | 17467628 11989578 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
2.85 | 17653716 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
5.04 | 12125929 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
4.58 | 17678736 17334414 17638931 16364871 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.69 | 15886252 |